Published Date: 31-Jan-2020
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report North America Retinal Imaging Devices Market, published by KBV Research, the North America Retinal Imaging Devices Market would witness market growth of 6.3% CAGR during the forecast period (2019-2025).
The USA market dominated the North America Fluorescein Angiography Market by Country in 2018, and would continue to be a dominant market till 2025. The Canada market is exhibiting to witness a CAGR of 6.7% during (2019 - 2025).
The Fundus Camera market dominated the Canada Retinal Imaging Market by Type in 2018, growing at a CAGR of 6.3 % during the forecast period. The Fluorescein Angiography market is exhibiting a CAGR of 6.7% during (2019 - 2025). The OCT market is anticipated to witness a CAGR of 7.6% during (2019 - 2025).
The Hospitals market dominated the Mexico Retinal Imaging Market by End-Use in 2018, thereby, achieving a market value of $86.1 Million by 2025. The Ophthalmic Centers market is expected to witness a CAGR of 8.5% during (2019 - 2025).
Report Structural Insights: https://www.kbvresearch.com/north-america-retinal-imaging-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Topcon Corporation, Carl Zeiss AG, Olympus Corporation, Robert Bosch GmbH (Bosch Healthcare), Revenio Group Oyj (CenterVue SpA), Nikon Corporation (Optos PLC), Optomed PLC, Epipole Ltd., Nidek Co., Ltd., and Eyenuk, Inc.
By End Use
Unique Offerings from KBV Research